Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis

scientific article published on 3 May 2017

Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1085120705
P356DOI10.1007/S12640-017-9740-Y
P932PMC publication ID5727154
P698PubMed publication ID28470570

P50authorNathan TorbickQ96162877
Elijah StommelQ114865340
P2093author name stringXun Shi
Patricia L Henegan
Tracie Caller
Ernst Linder
Angeline Andrew
Beth Ziniti
Jim Haney
Walter Bradley
P2860cites workThe non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregationQ21004125
Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern FranceQ21132388
Neurodegenerative causes of death among retired National Football League playersQ23912768
Cyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food websQ24618334
Agricultural pesticide use in California: pesticide prioritization, use densities, and population distributions for a childhood cancer studyQ24813206
Focality, stochasticity and neuroanatomic propagation in ALS pathogenesisQ26994792
The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosisQ26999594
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in GuamQ28210145
Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark finsQ28261789
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brainQ28272327
Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MDQ28290356
Association of lead exposure with survival in amyotrophic lateral sclerosisQ28384807
Modelling individual space–time exposure opportunities: A novel approach to unravelling the genetic or environment disease causation debateQ57231210
Lead Exposure as a Risk Factor for Amyotrophic Lateral SclerosisQ57420303
Barbara Tomik (1962–2010)Q58175120
Ecoregions of the Conterminous United StatesQ58282242
A Landsat Surface Reflectance Dataset for North America, 1990–2000Q58398850
Spatial and Spatio-Temporal Log-Gaussian Cox Processes: Extending the Geostatistical ParadigmQ58851835
Model-based geostatisticsQ58852207
Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998Q59701680
Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium contentQ71666507
Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumptionQ73381828
Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control studyQ80200087
Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosisQ85709871
Mapping amyotrophic lateral sclerosis lake risk factors across northern New EnglandQ28395864
Genetic GIScience: Toward a Place-Based Synthesis of the Genome, Exposome, and BehavomeQ30662971
copCAR: A Flexible Regression Model for Areal DataQ31018221
Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposureQ33927137
Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of GuamQ33973850
Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995-2004.Q34023702
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.Q34131994
Log Gaussian Cox processes and spatially aggregated disease incidence dataQ34250955
Interannual variability of cyanobacterial blooms in Lake ErieQ34369510
The effects of spatial population dataset choice on estimates of population at risk of diseaseQ34610934
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria bloomsQ35013964
Toxins and bioactive compounds from cyanobacteria and their implications on human healthQ35070610
Cyanobacterial toxins: risk management for health protectionQ36057610
A Multiscale Mapping Assessment of Lake Champlain Cyanobacterial Harmful Algal BloomsQ36102550
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosisQ37386444
Smoking may be considered an established risk factor for sporadic ALS.Q37459710
Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.Q37972904
The changing scene of amyotrophic lateral sclerosisQ38086771
Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.Q38091029
Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.Q38176187
A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis.Q38199669
Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New EnglandQ38403128
The Epidemiology of Amyotrophic Lateral Sclerosis in New Hampshire, USA, 2004-2007.Q38432137
Challenges for mapping cyanotoxin patterns from remote sensing of cyanobacteriaQ39078362
Motor neuron disease: epidemiologic studies.Q39766488
Prospective study of acute health effects in relation to exposure to cyanobacteriaQ40238643
Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis.Q41953178
Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study GroupQ42553190
Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009.Q44109735
Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreakQ44141382
Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin communityQ44676218
Effects of residual smoothing on the posterior of the fixed effects in disease-mapping modelsQ44868652
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's diseaseQ45292859
Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veteransQ45331854
Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study.Q50949745
ALS in Italian professional soccer players: the risk is still present and could be soccer-specific.Q55051587
Bayesian measures of model complexity and fitQ56532420
Bayesian image restoration, with two applications in spatial statisticsQ56559498
Log Gaussian Cox ProcessesQ56784715
P2507corrigendum / erratumErratum to: Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis.Q47698948
P433issue1
P921main subjectCyanobacteriaQ93315
amyotrophic lateral sclerosisQ206901
algal bloomQ326139
P304page(s)199-212
P577publication date2017-05-03
P1433published inNeurotoxicity ResearchQ15764278
P1476titleAssessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis
P478volume33

Reverse relations

cites work (P2860)
Q90117755Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease
Q64072480Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins
Q90265064Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis
Q89999946Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches
Q57125607Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases
Q93081287Production of β-methylamino-L-alanine (BMAA) and Its Isomers by Freshwater Diatoms

Q47698948Erratum to: Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis.main subjectP921